Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2023 | 2 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.
N Engl J Med. 2020 Jul 9;383(2):141-150. doi: 10.1056/NEJMoa1917006.
N Engl J Med. 2020.
PMID: 32640132
Clinical Trial.
Clinically meaningful improvements in cutaneous lesions and quality of life measures in patients with atopic dermatitis with greater pruritus reductions after treatment with 60 mg nemolizumab subcutaneously every 4 weeks: subgroup analysis from a phase 3, randomized, controlled trial.
Kabashima K, Matsumura T, Hayakawa Y, Kawashima M; Nemolizumab-JP01 Study Group.
Kabashima K, et al.
J Dermatolog Treat. 2023 Dec;34(1):2177096. doi: 10.1080/09546634.2023.2177096.
J Dermatolog Treat. 2023.
PMID: 36779675
Free article.
Clinical Trial.
Item in Clipboard
Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial.
Kabashima K, Matsumura T, Komazaki H, Kawashima M; Nemolizumab-JP01 Study Group.
Kabashima K, et al.
Dermatol Ther (Heidelb). 2023 Apr;13(4):997-1011. doi: 10.1007/s13555-023-00901-7. Epub 2023 Mar 11.
Dermatol Ther (Heidelb). 2023.
PMID: 36905481
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.